Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Clinical trial NCT05472857 · UNKNOWN

Trial details

NCT number: NCT05472857
Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Pancreatic Cancer Advanced Ovarian Carcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2022-08-08
Primary completion: 2024-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.